Therapeutic Apheresis and Long COVID

Jul 20, 2023
Source: www.odysee.com/@FrontlineCovid19CriticalCareAlliance:c/Therapeutic-Apheresis-and-Long-COVID:3

This study demonstrates the reduction in autoantibodies, inflammatory biomarkers, and erythrocyte stacking when extracorporeal apheresis is performed. Possibly an important intervention for patients that are struggling with long COVID for a prolonged period of time and are refractory to other therapies.

DrBeen: Medical Education Online
https://www.drbeen.com/